Liens rapides
Catégories
Fiches d'information
Les fiches d'information fournissent des informations supplémentaires sur l'industrie mondiale des protéines plasmatiques thérapeutiques.
Publications et présentations
Discover the main highlights of our industry in our latest publications.
Ressources pour les patients
Explorez les ressources de PPTA pour les patients intéressés par les thérapies aux protéines plasmatiques.
Rapports des parties prenantes
Apprenez-en plus en accédant à la collection de rapports de l'industrie.
Actualités et communiqués de presse
Restez au courant de l'actualité et des événements de l'Association.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mar 16, 2018
PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”
The article, “How Blood-Plasma Companies Target the Poorest Americans,” by H. Luke Shaefer and Analidis Ochoa, published in The Atlantic on March 15, was unfair to plasma donors as well as to individuals living with rare, genetic, and chronic diseases who rely on access to plasma protein therapies. Plasma donors are due our gratitude and respect, not sweeping negative characterizations.
All
PPTA statements
Mar 16, 2018
PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”
The article, “How Blood-Plasma Companies Target the Poorest Americans,” by H. Luke Shaefer and Analidis Ochoa, published in The Atlantic on March 15, was unfair to plasma donors as well as to individuals living with rare, genetic, and chronic diseases who rely on access to plasma protein therapies. Plasma donors are due our gratitude and respect, not sweeping negative characterizations.
All
PPTA statements
Mar 1, 2018
The Source Spring 2018
Magazine of the plasma protein therapeutics industry - Spring 2018
All
The Source Magazine
https://drive.google.com/file/d/1-qXwMdB9LODxAprdsmlCnzrFkR3YPn9H/view?usp=sharing
Mar 1, 2018
The Source Spring 2018
Magazine of the plasma protein therapeutics industry - Spring 2018
All
The Source Magazine
https://drive.google.com/file/d/1-qXwMdB9LODxAprdsmlCnzrFkR3YPn9H/view?usp=sharing
Feb 1, 2018
Key Economic & Value Considerations in the US Market for PPTs
Plasma protein therapies (PPTs) are biologic medicines that provide critical health benefits, especially for patients with plasma protein deficiencies. Plasma protein deficiencies are a group of chronic, serious, and mostly rare conditions that occur when a person has deficient or functionally damaged proteins in plasma—the liquid portion of blood.
All
Publication
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6454e9cb3bd98b1af1d2ac72_Key%20economic%20and%20value%20considerations%20in%20the%20U.S.%20market%20for%20plasma%20protein%20therapies.pdf
Feb 1, 2018
Key Economic & Value Considerations in the US Market for PPTs
Plasma protein therapies (PPTs) are biologic medicines that provide critical health benefits, especially for patients with plasma protein deficiencies. Plasma protein deficiencies are a group of chronic, serious, and mostly rare conditions that occur when a person has deficient or functionally damaged proteins in plasma—the liquid portion of blood.
All
Publication
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6454e9cb3bd98b1af1d2ac72_Key%20economic%20and%20value%20considerations%20in%20the%20U.S.%20market%20for%20plasma%20protein%20therapies.pdf
Jan 1, 2018
PPTA 2017 Annual Report
2017 annual report
All
PPTA Annual report
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453dfc489ffad29690d5077_2017%20PPTA%20Annual%20Report%20(1).pdf
Jan 1, 2018
PPTA 2017 Annual Report
2017 annual report
All
PPTA Annual report
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453dfc489ffad29690d5077_2017%20PPTA%20Annual%20Report%20(1).pdf
Aucun résultat n'a été trouvé